BCL2L11 and melanoma: By contrast, TRAIL–CDK9i drastically enhanced mitochondrial depolarization, strikingly achieving it even in the absence of exogenously added Bim peptide in all six melanoma cell lines, representing the three chemo-/targeted therapy-sensitive and -resistant melanoma cell line pairs (Fig. 5a and Supplementary Fig. 5a–c).